uniQure
+$0.74 (+2.33%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell uniQure and other stocks, options, and ETFs commission-free!
About QURE
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems.
CEO
Matthew C. Kapusta
Employees
332
Headquarters
Amsterdam, Noord-Holland
Founded
1998
QURE Key Statistics
Market Cap
1.54B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
397.39K
High Today
$32.64
Low Today
$31.50
Open Price
$31.64
Volume
303.36K
52 Week High
$71.45
52 Week Low
$28.58
Analyst Ratings
94%
of 17 ratings
Buy
94.1%
Hold
5.9%
Sell
0%
QURE Earnings
-$1.21
-$0.28
$0.65
$1.58
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$1.58 per share
Actual
-$0.91 per share